ETF Managers Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $147K | Buy |
+2,120
| New | +$147K | ﹤0.01% | 610 |
|
2022
Q4 | – | Sell |
-2,856
| Closed | -$157K | – | 533 |
|
2022
Q3 | $157K | Buy |
2,856
+155
| +6% | +$8.52K | 0.01% | 625 |
|
2022
Q2 | $181K | Sell |
2,701
-1,217
| -31% | -$81.6K | 0.01% | 653 |
|
2022
Q1 | $263K | Sell |
3,918
-3,012
| -43% | -$202K | 0.01% | 565 |
|
2021
Q4 | $405K | Sell |
6,930
-1,506
| -18% | -$88K | 0.01% | 549 |
|
2021
Q3 | $503K | Buy |
8,436
+2,036
| +32% | +$121K | 0.01% | 533 |
|
2021
Q2 | $385K | Sell |
6,400
-1,272
| -17% | -$76.5K | 0.01% | 567 |
|
2021
Q1 | $383K | Buy |
7,672
+568
| +8% | +$28.4K | 0.01% | 544 |
|
2020
Q4 | $356K | Buy |
7,104
+569
| +9% | +$28.5K | 0.01% | 506 |
|
2020
Q3 | $360K | Buy |
6,535
+3,940
| +152% | +$217K | 0.01% | 386 |
|
2020
Q2 | $137K | Buy |
+2,595
| New | +$137K | ﹤0.01% | 571 |
|